Nuclear haematology is the study of the pathophysiology, diagnosis, and treatment of haematological conditions using radionuclides or radiopharmaceutical substances. Radionuclides are currently commonly employed to label produced blood elements (random labels) in order to track their biological distribution, function, and lifespan in vivo, as well as to examine the proliferation and differentiation of hematopoietic progenitor and precursor cells in the bone marrow (cohort labels). The assessment of spleen size, splenic sequestration of blood cells, and investigations into the absorption, metabolism, and use of haematological nutrients such as iron, vitamin B12, and folate are some of the other primary applications of nuclear haematology. Many imaging techniques are progressively being used and studied to establish the anatomical distribution of hematopoietic tissues in the bone marrow and other organs, as well as to assess their importance in the diagnosis and therapy of various haematological illnesses.
Title : Cellular mechanisms involved in seronegative hemolysis
Donald R Branch, University of Toronto, Canada
Title : Immuno-Oncology (IO): 2023 and beyond
Stefan Gluck, Global Medical Affairs at Celgene Corporation, United States
Title : Managing bacterial eradication in disease and survival for life support systems on earth and space
A C Matin, Stanford Medical School, United States
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan LLuis Vives Corrons, University of Barcelona, Spain
Title : The complete evidence that starling’s law responsible for many errors and misconceptions on fluid therapy in shock is wrong: The correct replacement is the hydrodynamic phenomenon of the porous orifice (G) tube
Ahmed N Ghanem, Mansoura University, Egypt
Title : Breaking Down Mental Health Stigmas
Thad Cummings, Thad Cummings, United States